PLEKHG4 Gene Spinocerebellar ataxia type 4 autosomal dominant Genetic Test
Welcome to DNA Labs UAE, a leading genetic lab offering the PLEKHG4 Gene Spinocerebellar ataxia type 4 autosomal dominant Genetic Test.
Test Components
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on FTA Card.
Report Delivery
Your test results will be delivered within 3 to 4 weeks.
Method
We utilize NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
This test is specifically designed for Neurological Disorders.
Doctor
Your test will be conducted by a qualified Neurologist.
Test Department
This test is conducted in our Genetics department.
Pre Test Information
Before the test, we require the clinical history of the patient who is going for the PLEKHG4 Gene Spinocerebellar ataxia type 4 autosomal dominant Genetic Test. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with this genetic disorder.
Test Details
Spinocerebellar ataxia type 4 (SCA4) is an autosomal dominant genetic disorder that affects the cerebellum and spinal cord. It is caused by mutations in the PLEKHG4 gene. NGS genetic testing is a method used to analyze multiple genes simultaneously. In the case of SCA4, NGS can be used to identify mutations or variations in the PLEKHG4 gene that may be responsible for the development of the disorder.
The NGS genetic test for SCA4 involves obtaining a DNA sample, usually through a blood sample or cheek swab, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the PLEKHG4 gene. The results of the test can help confirm a diagnosis of SCA4 and provide information about the specific mutation present in the gene.
It is important to note that genetic testing for SCA4 should be conducted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support. They can help interpret the results and discuss the implications of the test for the individual and their family members.
Test Name | PLEKHG4 Gene Spinocerebellar ataxia type 4 autosomal dominant Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PLEKHG4 Gene Spinocerebellar ataxia type 4, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLEKHG4 Gene Spinocerebellar ataxia type 4, autosomal dominant |
Test Details |
Spinocerebellar ataxia type 4 (SCA4) is an autosomal dominant genetic disorder that affects the cerebellum and spinal cord. It is caused by mutations in the PLEKHG4 gene. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of SCA4, NGS can be used to identify mutations or variations in the PLEKHG4 gene that may be responsible for the development of the disorder. The NGS genetic test for SCA4 involves obtaining a DNA sample, usually through a blood sample or cheek swab, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the PLEKHG4 gene. The results of the test can help confirm a diagnosis of SCA4 and provide information about the specific mutation present in the gene. It is important to note that genetic testing for SCA4 should be conducted by a qualified healthcare professional or genetic counselor who can provide appropriate counseling and support. They can help interpret the results and discuss the implications of the test for the individual and their family members. |